CSPC PHARMACEUTICAL GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.44 HKD | -1.08% |
|
-4.31% | -11.29% |
ETFs positioned on CSPC Pharmaceutical Group Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.05% | 2 M€ | -16.67% | - | |
| 2.02% | 4 M€ | -27.92% | ||
| 1.07% | 3 M€ | +4.49% | - | |
| 0.99% | 2 M€ | -14.14% | ||
| 0.86% | 4 M€ | -11.56% | ||
| 0.53% | 19 M€ | +8.87% | ||
| 0.26% | 11 M€ | +6.62% | ||
| 0.23% | 35 M€ | -5.85% | - | |
| 0.23% | 1 M€ | +3.49% | - | |
| 0.23% | 3 M€ | -.--% | - | |
| 0.10% | 454 M€ | +8.42% | - | |
| 0.10% | 2,867 M€ | +10.11% | - | |
| 0.10% | 153 M€ | +7.93% | - | |
| 0.09% | 112 M€ | +3.77% | - | |
| 0.08% | 4 M€ | -4.41% | - | |
| 0.05% | 0 M€ | 0.00% | - | |
| 0.04% | 32 M€ | +6.91% | - | |
| 0.03% | 7 M€ | +0.11% | - | |
| 0.02% | 45 M€ | 0.00% | - | |
| 0.02% | 391 M€ | +9.34% | - | |
| 0.02% | 34 M€ | +9.41% | - | |
| 0.01% | 7 M€ | +4.98% | - | |
| 0.01% | 39 M€ | +6.13% | - | |
| 0.01% | 306 M€ | +6.59% | - | |
| 0.01% | 17 M€ | +3.49% | - | |
| 0.01% | 34 M€ | +3.53% | - | |
| 0.01% | 105 M€ | +3.84% | - |
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
Pharmaceuticals
Calendar
2024-05-26
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6.44
HKD
Average target price
9.382
HKD
Spread / Average Target
+45.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.29% | 9.88B | |
| +38.69% | 723B | |
| +34.28% | 595B | |
| -4.49% | 369B | |
| +20.24% | 332B | |
| +2.12% | 282B | |
| +17.02% | 244B | |
| +9.31% | 208B | |
| -5.07% | 205B | |
| -0.35% | 168B |
- Stock Market
- Equities
- 1093 Stock
- Funds and ETFs CSPC Pharmaceutical Group Ltd.
